220 related articles for article (PubMed ID: 12172906)
21. Breached cerebral glia limitans-basal lamina complex in Fukuyama-type congenital muscular dystrophy.
Saito Y; Murayama S; Kawai M; Nakano I
Acta Neuropathol; 1999 Oct; 98(4):330-6. PubMed ID: 10502035
[TBL] [Abstract][Full Text] [Related]
22. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
Hu H; Yang Y; Eade A; Xiong Y; Qi Y
J Comp Neurol; 2007 Mar; 501(1):168-83. PubMed ID: 17206611
[TBL] [Abstract][Full Text] [Related]
23. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
24. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
[TBL] [Abstract][Full Text] [Related]
25. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy.
Kobayashi K; Nakahori Y; Miyake M; Matsumura K; Kondo-Iida E; Nomura Y; Segawa M; Yoshioka M; Saito K; Osawa M; Hamano K; Sakakihara Y; Nonaka I; Nakagome Y; Kanazawa I; Nakamura Y; Tokunaga K; Toda T
Nature; 1998 Jul; 394(6691):388-92. PubMed ID: 9690476
[TBL] [Abstract][Full Text] [Related]
26. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
Taniguchi M; Kurahashi H; Noguchi S; Fukudome T; Okinaga T; Tsukahara T; Tajima Y; Ozono K; Nishino I; Nonaka I; Toda T
Hum Mol Genet; 2006 Apr; 15(8):1279-89. PubMed ID: 16531417
[TBL] [Abstract][Full Text] [Related]
27. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K
Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638
[TBL] [Abstract][Full Text] [Related]
28. Immature astrocytes in Fukuyama congenital muscular dystrophy: an immunohistochemical study.
Yamamoto T; Armstrong D; Shibata N; Kanazawa M; Kobayashi M
Pediatr Neurol; 1999 Jan; 20(1):31-7. PubMed ID: 10029257
[TBL] [Abstract][Full Text] [Related]
29. The mildest known case of Fukuyama-type congenital muscular dystrophy.
Akiyama T; Ohtsuka Y; Takata T; Hattori J; Kawakita Y; Saito K
Brain Dev; 2006 Sep; 28(8):537-40. PubMed ID: 16603329
[TBL] [Abstract][Full Text] [Related]
30. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
Hu H; Yang Y; Eade A; Xiong Y; Qi Y
J Comp Neurol; 2007 May; 502(2):168-83. PubMed ID: 17479518
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy.
Yoshioka M
Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy.
Hino N; Kobayashi M; Shibata N; Yamamoto T; Saito K; Osawa M
Brain Dev; 2001 Mar; 23(2):97-107. PubMed ID: 11248458
[TBL] [Abstract][Full Text] [Related]
33. Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy.
Yamamoto T; Toyoda C; Kobayashi M; Kondo E; Saito K; Osawa M
Brain Dev; 1997 Jan; 19(1):35-42. PubMed ID: 9071488
[TBL] [Abstract][Full Text] [Related]
34. Neuronal and glial expression of the adhesion molecule TAG-1 is regulated after peripheral nerve lesion or central neurodegeneration of adult nervous system.
Soares S; Traka M; von Boxberg Y; Bouquet C; Karagogeos D; Nothias F
Eur J Neurosci; 2005 Mar; 21(5):1169-80. PubMed ID: 15813926
[TBL] [Abstract][Full Text] [Related]
35. Distribution of Aquaporin 9 in the adult rat brain: preferential expression in catecholaminergic neurons and in glial cells.
Badaut J; Petit JM; Brunet JF; Magistretti PJ; Charriaut-Marlangue C; Regli L
Neuroscience; 2004; 128(1):27-38. PubMed ID: 15450351
[TBL] [Abstract][Full Text] [Related]
36. Identification of a functional CRE in the promoter of Fukuyama congenital muscular dystrophy gene fukutin.
Fang H; Sodja C; Chartier J; Desbois A; Lei J; Walker PR; Sikorska M
Brain Res Mol Brain Res; 2005 May; 136(1-2):1-11. PubMed ID: 15893581
[TBL] [Abstract][Full Text] [Related]
37. [Fukuyama congenital muscular dystrophy--history and perspectives].
Fukuyama Y
Brain Nerve; 2008 Jan; 60(1):43-51. PubMed ID: 18232332
[TBL] [Abstract][Full Text] [Related]
38. Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain.
Moldrich RX; Lainé J; Visel A; Beart PM; Laffaire J; Rossier J; Potier MC
Neuroscience; 2008 Jul; 154(4):1255-66. PubMed ID: 18541381
[TBL] [Abstract][Full Text] [Related]
39. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
40. Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly.
Furuta A; Takashima S; Yokoo H; Rothstein JD; Wada K; Iwaki T
Brain Res Dev Brain Res; 2005 Mar; 155(2):155-64. PubMed ID: 15804404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
